Objective: To evaluate the effectiveness of a mobile health (mHealth)-based smart management strategy for reducing the risk of gastrointestinal bleeding in patients with cardiovascular disease undergoing anticoagulant therapy.
Method: A retrospective observational study was conducted in a tertiary hospital, with patients undergoing anticoagulant therapy being allocated to conventional and smart groups. mHealth technology-based monitoring tools, standardized questionnaires for disease knowledge and self-assessment scales for anxiety and depression were used.
Results: Related to hemostasis and satisfaction with the nursing staff were evaluated using t-tests and chi-square tests; p-values <0.05 were considered significant.
Results: The mHealth-based smart management strategy showed a positive association with disease knowledge, a better psychological state, a shorter hemostasis time, and greater satisfaction with nursing care (P < 0.05).
Conclusion: A smart management strategy based on mHealth was associated with better clinical and psychological outcomes than the conventional guidance group.
DESCRIPTORS
Blood Coagulation; Cardiovascular Disease; Gastrointestinal Hemorrhage; Intelligence; Risk.